A vitória da patente do teste pré-natal da Ravgen aumentou para US$ 372 milhões – Law360

By Jasmin Boyce (May 15, 2023, 4:51 PM EDT) — U.S. District Judge Alan Albright has agreed to enhance biotechnology company Ravgen’s $272 million jury award in its patent suit against rival Labcorp over a testing method for genetic disorders, adding $100 million to the jury verdict partly because the infringement occurred “for a long time.”…